Miriam Pons
Obere Zahlbacher Str. 67
Mainz, RP 55131, Germany
Mainz, RP 55131, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
ADJUBIL: phase II study of adjuvant immunotherapy with STRIDE regimen with/without capecitabine in biliary tract cancers.
Journal: Future oncology (London, England)
Published: February 27, 2024
Colony Formation Assay to Test the Impact of HDACi on Leukemic Cells.
Journal: Methods in molecular biology (Clifton, N.J.)
Published: October 18, 2022
Human Platelet Lysate as Valid Cell Growth Additive to Assess Protein Acetylation.
Journal: Methods in molecular biology (Clifton, N.J.)
Published: October 18, 2022
NOXA expression drives synthetic lethality to RUNX1 inhibition in pancreatic cancer.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: November 23, 2021
Oncogenic Kinase Cascades Induce Molecular Mechanisms That Protect Leukemic Cell Models from Lethal Effects of De Novo dNTP Synthesis Inhibition.
Journal: Cancers
Published: April 29, 2021
The PP2A subunit PR130 is a key regulator of cell development and oncogenic transformation.
Journal: Biochimica et biophysica acta. Reviews on cancer
Published: July 29, 2020
Human platelet lysate as validated replacement for animal serum to assess chemosensitivity.
Journal: ALTEX
Published: September 21, 2018
Loss of Wilms tumor 1 protein is a marker for apoptosis in response to replicative stress in leukemic cells.
Journal: Archives of toxicology
Published: March 16, 2018
Showing 1-9 of 9
Last Updated: 09/26/2026